Selected research
Market Structure
Global Memantine Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Memantine Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Memantine Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Memantine Hydrochloride Tablets include Teva Pharmaceuticals USA, Sun Pharma, United Laboratories, Upsher-Smith, Taj Pharma India Limited, Sharon Bio-medicine Limited, Psycogen Captab, Kabir Lifesciences and Consern Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Memantine Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Memantine Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Memantine Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Memantine Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Memantine Hydrochloride Tablets Segment by Company
Teva Pharmaceuticals USA
Sun Pharma
United Laboratories
Upsher-Smith
Taj Pharma India Limited
Sharon Bio-medicine Limited
Psycogen Captab
Kabir Lifesciences
Consern Pharma Limited
Aripolis Biotech Pvt. Ltd.
Ajanta Pharma Ltd.
Actiza Pharmaceutical Pvt. Ltd.
Memantine Hydrochloride Tablets Segment by Type
Immediate-Release Tablets
Extended-Release Tablets
Memantine Hydrochloride Tablets Segment by Application
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Memantine Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Memantine Hydrochloride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Memantine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Memantine Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Immediate-Release Tablets
- Extended-Release Tablets
Applications
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Companies covered
- Teva Pharmaceuticals USA
- Sun Pharma
- United Laboratories
- Upsher-Smith
- Taj Pharma India Limited
- Sharon Bio-medicine Limited
- Psycogen Captab
- Kabir Lifesciences
- Consern Pharma Limited
- Aripolis Biotech Pvt. Ltd.
- Ajanta Pharma Ltd.
- Actiza Pharmaceutical Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Memantine Hydrochloride Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Memantine Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Memantine Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Memantine Hydrochloride Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Memantine Hydrochloride Tablets Market Dynamics
- 2.1 Memantine Hydrochloride Tablets Industry Trends
- 2.2 Memantine Hydrochloride Tablets Industry Drivers
- 2.3 Memantine Hydrochloride Tablets Industry Opportunities and Challenges
- 2.4 Memantine Hydrochloride Tablets Industry Restraints
3 Memantine Hydrochloride Tablets Market by Manufacturers
- 3.1 Global Memantine Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Memantine Hydrochloride Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Memantine Hydrochloride Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Memantine Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Memantine Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Memantine Hydrochloride Tablets Manufacturers, Product Type & Application
- 3.7 Global Memantine Hydrochloride Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Memantine Hydrochloride Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Memantine Hydrochloride Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Memantine Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Memantine Hydrochloride Tablets Market by Type
- 4.1 Memantine Hydrochloride Tablets Type Introduction
- 4.1.1 Immediate-Release Tablets
- 4.1.2 Extended-Release Tablets
- 4.2 Global Memantine Hydrochloride Tablets Sales by Type
- 4.2.1 Global Memantine Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Memantine Hydrochloride Tablets Sales by Type (2021-2032)
- 4.2.3 Global Memantine Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Memantine Hydrochloride Tablets Revenue by Type
- 4.3.1 Global Memantine Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Memantine Hydrochloride Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Memantine Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
5 Memantine Hydrochloride Tablets Market by Application
- 5.1 Memantine Hydrochloride Tablets Application Introduction
- 5.1.1 Retail Pharmacy
- 5.1.2 Hospital Pharmacy
- 5.1.3 Online Pharmacy
- 5.2 Global Memantine Hydrochloride Tablets Sales by Application
- 5.2.1 Global Memantine Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Memantine Hydrochloride Tablets Sales by Application (2021-2032)
- 5.2.3 Global Memantine Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Memantine Hydrochloride Tablets Revenue by Application
- 5.3.1 Global Memantine Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Memantine Hydrochloride Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Memantine Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
6 Global Memantine Hydrochloride Tablets Sales by Region
- 6.1 Global Memantine Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Memantine Hydrochloride Tablets Sales by Region (2021-2032)
- 6.2.1 Global Memantine Hydrochloride Tablets Sales by Region (2021-2026)
- 6.2.2 Global Memantine Hydrochloride Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Memantine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Memantine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Memantine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Memantine Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Memantine Hydrochloride Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Memantine Hydrochloride Tablets Revenue by Region
- 7.1 Global Memantine Hydrochloride Tablets Revenue by Region
- 7.1.1 Global Memantine Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Memantine Hydrochloride Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Memantine Hydrochloride Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Memantine Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Memantine Hydrochloride Tablets Revenue (2021-2032)
- 7.2.2 North America Memantine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Memantine Hydrochloride Tablets Revenue (2021-2032)
- 7.3.2 Europe Memantine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Memantine Hydrochloride Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Memantine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Memantine Hydrochloride Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Memantine Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceuticals USA
- 8.1.1 Teva Pharmaceuticals USA Company Information
- 8.1.2 Teva Pharmaceuticals USA Business Overview
- 8.1.3 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceuticals USA Memantine Hydrochloride Tablets Product Portfolio
- 8.1.5 Teva Pharmaceuticals USA Recent Developments
- 8.2 Sun Pharma
- 8.2.1 Sun Pharma Company Information
- 8.2.2 Sun Pharma Business Overview
- 8.2.3 Sun Pharma Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharma Memantine Hydrochloride Tablets Product Portfolio
- 8.2.5 Sun Pharma Recent Developments
- 8.3 United Laboratories
- 8.3.1 United Laboratories Company Information
- 8.3.2 United Laboratories Business Overview
- 8.3.3 United Laboratories Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 United Laboratories Memantine Hydrochloride Tablets Product Portfolio
- 8.3.5 United Laboratories Recent Developments
- 8.4 Upsher-Smith
- 8.4.1 Upsher-Smith Company Information
- 8.4.2 Upsher-Smith Business Overview
- 8.4.3 Upsher-Smith Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Upsher-Smith Memantine Hydrochloride Tablets Product Portfolio
- 8.4.5 Upsher-Smith Recent Developments
- 8.5 Taj Pharma India Limited
- 8.5.1 Taj Pharma India Limited Company Information
- 8.5.2 Taj Pharma India Limited Business Overview
- 8.5.3 Taj Pharma India Limited Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Taj Pharma India Limited Memantine Hydrochloride Tablets Product Portfolio
- 8.5.5 Taj Pharma India Limited Recent Developments
- 8.6 Sharon Bio-medicine Limited
- 8.6.1 Sharon Bio-medicine Limited Company Information
- 8.6.2 Sharon Bio-medicine Limited Business Overview
- 8.6.3 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sharon Bio-medicine Limited Memantine Hydrochloride Tablets Product Portfolio
- 8.6.5 Sharon Bio-medicine Limited Recent Developments
- 8.7 Psycogen Captab
- 8.7.1 Psycogen Captab Company Information
- 8.7.2 Psycogen Captab Business Overview
- 8.7.3 Psycogen Captab Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Psycogen Captab Memantine Hydrochloride Tablets Product Portfolio
- 8.7.5 Psycogen Captab Recent Developments
- 8.8 Kabir Lifesciences
- 8.8.1 Kabir Lifesciences Company Information
- 8.8.2 Kabir Lifesciences Business Overview
- 8.8.3 Kabir Lifesciences Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Kabir Lifesciences Memantine Hydrochloride Tablets Product Portfolio
- 8.8.5 Kabir Lifesciences Recent Developments
- 8.9 Consern Pharma Limited
- 8.9.1 Consern Pharma Limited Company Information
- 8.9.2 Consern Pharma Limited Business Overview
- 8.9.3 Consern Pharma Limited Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Consern Pharma Limited Memantine Hydrochloride Tablets Product Portfolio
- 8.9.5 Consern Pharma Limited Recent Developments
- 8.10 Aripolis Biotech Pvt. Ltd.
- 8.10.1 Aripolis Biotech Pvt. Ltd. Company Information
- 8.10.2 Aripolis Biotech Pvt. Ltd. Business Overview
- 8.10.3 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Aripolis Biotech Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 8.10.5 Aripolis Biotech Pvt. Ltd. Recent Developments
- 8.11 Ajanta Pharma Ltd.
- 8.11.1 Ajanta Pharma Ltd. Company Information
- 8.11.2 Ajanta Pharma Ltd. Business Overview
- 8.11.3 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Ajanta Pharma Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 8.11.5 Ajanta Pharma Ltd. Recent Developments
- 8.12 Actiza Pharmaceutical Pvt. Ltd.
- 8.12.1 Actiza Pharmaceutical Pvt. Ltd. Company Information
- 8.12.2 Actiza Pharmaceutical Pvt. Ltd. Business Overview
- 8.12.3 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Actiza Pharmaceutical Pvt. Ltd. Memantine Hydrochloride Tablets Product Portfolio
- 8.12.5 Actiza Pharmaceutical Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Memantine Hydrochloride Tablets Value Chain Analysis
- 9.1.1 Memantine Hydrochloride Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Memantine Hydrochloride Tablets Production Mode & Process
- 9.2 Memantine Hydrochloride Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Memantine Hydrochloride Tablets Distributors
- 9.2.3 Memantine Hydrochloride Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst